Ameriprise Financial Inc. raised its position in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 9.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 37,992 shares of the semiconductor company's stock after buying an additional 3,436 shares during the quarter. Ameriprise Financial Inc. owned about 0.12% of Silicon Laboratories worth $4,719,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of the business. Barclays PLC raised its position in Silicon Laboratories by 23.4% in the third quarter. Barclays PLC now owns 70,568 shares of the semiconductor company's stock valued at $8,157,000 after purchasing an additional 13,363 shares during the last quarter. Park Avenue Securities LLC bought a new stake in Silicon Laboratories in the fourth quarter worth approximately $268,000. Nisa Investment Advisors LLC boosted its stake in Silicon Laboratories by 6.2% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,134 shares of the semiconductor company's stock worth $514,000 after acquiring an additional 240 shares in the last quarter. SG Americas Securities LLC increased its position in Silicon Laboratories by 1,106.4% in the 4th quarter. SG Americas Securities LLC now owns 23,791 shares of the semiconductor company's stock valued at $2,955,000 after buying an additional 21,819 shares in the last quarter. Finally, KBC Group NV increased its holdings in shares of Silicon Laboratories by 42.1% during the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company's stock valued at $159,000 after acquiring an additional 379 shares in the last quarter.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the company. Benchmark reiterated a "buy" rating and set a $160.00 price target on shares of Silicon Laboratories in a report on Tuesday. Barclays decreased their price objective on Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating for the company in a report on Tuesday, April 22nd. Wall Street Zen upgraded Silicon Laboratories from a "sell" rating to a "hold" rating in a research note on Wednesday, May 14th. Needham & Company LLC reissued a "buy" rating and issued a $150.00 price target on shares of Silicon Laboratories in a report on Wednesday, May 14th. Finally, Susquehanna raised their target price on shares of Silicon Laboratories from $100.00 to $110.00 and gave the company a "neutral" rating in a research note on Wednesday, May 14th. Four equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, Silicon Laboratories presently has a consensus rating of "Moderate Buy" and an average target price of $126.50.
Check Out Our Latest Analysis on Silicon Laboratories
Silicon Laboratories Price Performance
Silicon Laboratories stock traded down $2.44 during trading hours on Friday, reaching $121.34. The company had a trading volume of 30,410 shares, compared to its average volume of 336,340. Silicon Laboratories Inc. has a 12-month low of $82.82 and a 12-month high of $160.00. The firm has a market cap of $3.95 billion, a price-to-earnings ratio of -20.40 and a beta of 1.36. The company has a 50-day moving average price of $108.75 and a 200 day moving average price of $121.98.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its earnings results on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.01. The firm had revenue of $177.71 million for the quarter, compared to analysts' expectations of $177.48 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The business's revenue was up 67.0% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.92) earnings per share. As a group, research analysts expect that Silicon Laboratories Inc. will post -0.97 earnings per share for the current year.
Insiders Place Their Bets
In other news, Director Christy Wyatt sold 546 shares of the company's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $104.45, for a total transaction of $57,029.70. Following the transaction, the director now directly owns 8,492 shares of the company's stock, valued at $886,989.40. This represents a 6.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Robert J. Conrad sold 4,029 shares of the business's stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of $131.20, for a total transaction of $528,604.80. Following the transaction, the senior vice president now directly owns 25,380 shares of the company's stock, valued at $3,329,856. The trade was a 13.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 11,626 shares of company stock worth $1,509,319. 1.60% of the stock is currently owned by company insiders.
About Silicon Laboratories
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Further Reading

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report